Mirena - Medsafe
MIRENA® CMI 2 young women who have not had a baby. When you must not use it Do not use Mirena if you have an allergy to: • levonorgestrel, the active
Download Mirena - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Mirena Manual de Anticoncepção On Line
www.anticoncepcao.org.brMirena Manual de Anticoncepção On Line Copyright 2000-2001 Anticoncepção On Line Todos os direitos reservados Visite – http://www.anticoncepcao.org.br 10 1 ...
ARCH - Bayer US Patient Assistance Foundation Application ...
www.archpatientassistance.comThe patient must meet all of the following ARCH program eligibility requirements: Patient does not have access to private or public insurance coverage for Kyleena ®, Mirena or Skyla Patient meets the ARCH program’s financial criteria for assistance, and provides acceptable
This page and its contents MIRENA ... - British Fibroid Trust
www.britishfibroidtrust.org.ukMirena for HMB Q&A Page 3 • Decreased libido (sex drive). This is not officially reported but was raised by a number of women on health's forum.
DATA SHEET 1. MIRENA 52 mg intrauterine contraceptive ...
www.medsafe.govt.nz180215 MIRENA DS 3 When required for perimenopausal contraception and endometrial protection during short-term estrogen replacement therapy, MIRENA can …
mirena patient information - Mirena Global Website
www.mirena.comPage: 1 of 17 Mirena patient information This provides medical and scientific information on Mirena in general. Please refer to the local Patient Information Leaflet for the information applicable in your country.
HIGHLIGHTS OF PRESCRIBING INFORMATION MIRENA.
labeling.bayerhealthcare.comNDA 21225 Mirena FDA Approved 08 June 2017 Inserting Mirena after Childbirth Do not insert Mirena until a minimum of 6 weeks after delivery, or until the uterus is fully involuted. If …
FDA-Approved Patient Labeling Patient Information Mirena ...
labeling.bayerhealthcare.comNDA 21225 Mirena FDA Approved 08 June 2017 What if I want to stop using Mirena? Mirena is intended for long-term use but you can stop using Mirena at any time by asking your